Literature DB >> 12731063

Inactivation of the EGF-TM7 receptor EMR4 after the Pan-Homo divergence.

Jörg Hamann1, Mark J Kwakkenbos, Esther C de Jong, Henk Heus, Anne S Olsen, René A W van Lier.   

Abstract

We here report on the identification of a novel human EGF-TM7 receptor, designated EMR4. Like most EGF-TM7 receptor genes, EMR4 is localized on the short arm of chromosome 19, in close proximity to EMR1. Remarkably, due to a one-nucleotide deletion in exon 8, translation of human EMR4 would result in a truncated 232-amino acid protein lacking the entire seven-span transmembrane region. This deletion is not present in nonhuman primates, including chimpanzees, suggesting that EMR4 became nonfunctional only after human speciation, about five million years ago. Thus, EMR4 surprisingly accounts for a genetic difference between humans and primates related to immunity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12731063     DOI: 10.1002/eji.200323881

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

1.  Human-specific nonsense mutations identified by genome sequence comparisons.

Authors:  Yoonsoo Hahn; Byungkook Lee
Journal:  Hum Genet       Date:  2006-02-10       Impact factor: 4.132

2.  The EGF-TM7 family of the rat.

Authors:  Jörg Hamann
Journal:  Immunogenetics       Date:  2004-11-11       Impact factor: 2.846

Review 3.  International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors.

Authors:  Jörg Hamann; Gabriela Aust; Demet Araç; Felix B Engel; Caroline Formstone; Robert Fredriksson; Randy A Hall; Breanne L Harty; Christiane Kirchhoff; Barbara Knapp; Arunkumar Krishnan; Ines Liebscher; Hsi-Hsien Lin; David C Martinelli; Kelly R Monk; Miriam C Peeters; Xianhua Piao; Simone Prömel; Torsten Schöneberg; Thue W Schwartz; Kathleen Singer; Martin Stacey; Yuri A Ushkaryov; Mario Vallon; Uwe Wolfrum; Mathew W Wright; Lei Xu; Tobias Langenhan; Helgi B Schiöth
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

Review 4.  Adhesion G protein-coupled receptors: structure, signaling, physiology, and pathophysiology.

Authors:  Trisha Lala; Randy A Hall
Journal:  Physiol Rev       Date:  2022-04-25       Impact factor: 46.500

Review 5.  Reconstructing phylogenies and phenotypes: a molecular view of human evolution.

Authors:  Brenda J Bradley
Journal:  J Anat       Date:  2008-04       Impact factor: 2.610

Review 6.  International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands.

Authors:  Anthony P Davenport; Stephen P H Alexander; Joanna L Sharman; Adam J Pawson; Helen E Benson; Amy E Monaghan; Wen Chiy Liew; Chidochangu P Mpamhanga; Tom I Bonner; Richard R Neubig; Jean Philippe Pin; Michael Spedding; Anthony J Harmar
Journal:  Pharmacol Rev       Date:  2013-05-17       Impact factor: 25.468

Review 7.  The EGF-TM7 family: a postgenomic view.

Authors:  Mark J Kwakkenbos; Else N Kop; Martin Stacey; Mourad Matmati; Siamon Gordon; Hsi-Hsien Lin; Jörg Hamann
Journal:  Immunogenetics       Date:  2003-11-27       Impact factor: 2.846

8.  ADGRE1 (EMR1, F4/80) Is a Rapidly-Evolving Gene Expressed in Mammalian Monocyte-Macrophages.

Authors:  Lindsey A Waddell; Lucas Lefevre; Stephen J Bush; Anna Raper; Rachel Young; Zofia M Lisowski; Mary E B McCulloch; Charity Muriuki; Kristin A Sauter; Emily L Clark; Katharine M Irvine; Clare Pridans; Jayne C Hope; David A Hume
Journal:  Front Immunol       Date:  2018-10-01       Impact factor: 7.561

9.  Gene losses during human origins.

Authors:  Xiaoxia Wang; Wendy E Grus; Jianzhi Zhang
Journal:  PLoS Biol       Date:  2006-02-14       Impact factor: 8.029

10.  INDELSCAN: a web server for comparative identification of species-specific and non-species-specific insertion/deletion events.

Authors:  Feng-Chi Chen; Chueng-Jong Chen; Trees-Juen Chuang
Journal:  Nucleic Acids Res       Date:  2007-05-21       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.